Peptide-mediated immune responses in specific immunotherapy

International Archives of Allergy and Immunology

Volumn 122, Issue 4, 2000, Pages 229-237

  Haselden, Brigitte M ^a   Kay, A Barry ^a   Larché, Mark ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Epitope; Immunotherapy; MHC; Peptide; Tolerance

Indexed keywords

ADRENALIN; ALLERGEN; EPITOPE; HLA ANTIGEN; SYNTHETIC PEPTIDE;

ALLERGIC REACTION; ALLERGY; ANTIGEN RECOGNITION; ASTHMA; CLINICAL TRIAL; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; HELPER CELL; HUMAN; HYPERSENSITIVITY; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOTHERAPY; INSECT ALLERGY; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE ACTIVATION;

EID: 0033814069     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000024403     Document Type: Review

References (69)

1. Durham SR, Walker SM, Varga E-M, Jacobson MR, O'Brien F, Noble W, Till SJ, Hamid QA, Nouri-Aria KT: Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med 1999;341:468-475.
2. Allergen immunotherapy: Therapeutic vaccines for allergic diseases. Geneva: January 27-29. Allergy 1998;53(suppl 44):1-42.
3. Nacleiro RM: Pathophysiology of perennial allergic rhinitis. Allergy 1997;52:7-13.
4. Varney V, Jacobson MR, Sudderick R, Robinson DS, Irani A, Varney VA, Schwartz LB, Mackay IS, Kay AB, Durham SR: Immunohistology of the nasal mucosa following allergen-induced rhinitis. Identification of activated T lymphocytes, eosinophils and neutrophils. Am Rev Respir Dis 1992;146:170-176.
5. Haselden BM, Kay AB, Larché M: Immunoglobulin-independent major histocompatibility complex-restricted T cell peptide epitope-induced late asthmatic reactions. J Exp Med 1999;189:1885-1894.
6. Kay AB: Concepts of allergy and hypersensitivity; in Kay AB (ed): Allergy and Allergic Diseases. Oxford, Blackwell Science, 1997, vol 1, pp 23-35.
7. Kon OM, Kay AB: Anti-T cell strategies in asthma. Inflamm Res 1999;48:516-523.
8. Hamid Q, Boguniewiecz M, Leung DYM: Differential in situ gene expression in acute versus chronic atopic dermatitis. J Clin Invest 1994; 94:870-876.
9. Hoyne GF, Askonas BA, Hetzel C, Thomas WR, Lamb JR: Regulation of house dust mite responses by intranasally administered peptide: Transient activation of CD4+ T cells precedes the development of tolerance in vivo. Int Immunol 1996;8:335-342.
10. Briner TJ, Kuo MC, Keating KM, Rogers BL, Greenstein JL: Peripheral T-cell tolerance induced in naive and primed mice by subcutaneous injection of peptides from the major cat allergen Fel d 1. Proc Natl Acad Sci USA 1993; 90:7608-7612.
11. Braciale TJ, Morrison LA, Sweetson MT, Sambrook J, Gething MJ, Braciale VL: Antigen presentation pathways to class I and class II MHC-restricted T lymphocytes. Immunol Rev 1987; 98:95-114.
12. Germain RN: The ins and outs of antigen processing and presentation. Nature 1986;322: 687-689.
13. d. Science 1992;256:1817-1820.
14. Neefjes JJ, Momburg F: Cell biology of antigen presentation. Curr Opin Immunol 1993;5:27-34.
15. Schwartz RH: Costimulation of T lymphocytes: The role of CD28, CTLA-4 and B7/BB1 in interleukin-2 production and immunotherapy. Cell 1992;71:1065-1068.
16. Larché M, Till SJ, Haselden BM, North J, Barkans J, Corrigan CJ, Kay AB, Robinson DS: Costimulation through CD86 is involved in airway antigen-presenting cell and T cell responses to allergen in atopic asthmatics. J Immunol 1998;161:6375-6382.
17. Casolaro V, Georas SN, Song Z, Ono SJ; Biology and genetics of atopic disease. Curr Opin Immunol 1996;8:796-803.
18. Kumar V, Bhardwaj V, Soares L, Alexander J, Sette A, Sercarz E: Major histocompatibility complex binding affinity of an antigenic determinant is crucial for the differential secretion of interleukin 4/5 or interferon gamma by T cells. Proc Natl Acad Sci USA 1995;92:9510-9514.
19. Murray JS, Pfeiffer C, Madri J, Bottomly K: Major histocompatibility complex (MHC) control of CD4 T cell subset activation. II. A single peptide induces either humoral or cell-mediated responses in mice of distinct MHC genotype. Eur J Immunol 1992;22:559-565.
20. Pfeiffer C, Stein J, Southwood S, Ketelaar H, Sette A, Bottomly K: Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo. J Exp Med 1995;181:1569-1574.
21. Hosken NA, Shibuya K, Heath AW, Murphy KM, O'Garra A: The effect of antigen dose on CD4+ T helper cell phenotype development in a T cell receptor-alpha beta-transgenic model. J Exp Med 1995;182:1579-1584.
22. Guery JC, Galbiati F, Smiroldo S, Adorini L: Selective development of T helper (Th)2 cells induced by continuous administration of low dose soluble proteins to normal and beta(2)-microglobulin-deficient BALB/c mice. J Exp Med 1996;183:485-497.
23. O'Garra A: Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 1998;8:275-278.
24. Van Neerven RJ, Ebner C, Yssel H, Kapsenberg ML, Lamb J: T-cell responses to allergens: Epitope-specificity and clinical relevance. Immunol Today 1996;17:526-534.
25. Young RP, Dekker JW, Wordsworth BP, Schou C, Pile KD, Matthiesen F, Rosenberg WM, Bell JI, Hopkin JM, Cookson WO: HLA-DR and HLA-DP genotypes and immunoglobulin E responses to common major allergens. Clin Exp Allergy 1994;24:431-439.
26. Marsh DG, Hsu SH, Roebber M, Ehrlich-Kautzky E, Freidhoff LR, Meyers DA, Pollard MK, Bias WB: HLA-Dw2: A genetic marker for human immune response to short ragweed pollen allergen Ra5. I. Response resulting primarily from natural antigenic exposure. J Exp Med 1982;155:1439-1451.
27. Scheiner O, Kraft D: Basic and practical aspects of recombinant allergens. Allergy 1995; 50:384-391.
28. van't Hof W, van Milligen FJ, van den Berg M, Lombardero M, Chapman MD, Aalberse R: Epitope mapping of the cat (Felis domesticus) major allergen Fel d 1 by overlapping synthetic peptides and monoclonal antibodies against native and denatured Fel d 1. Allergy 1993;48: 255-261.
29. Counsell CM, Bond JF, Ohman JR, Greenstein JL, Garman RD: Definition of the human T-cell epitopes of Fel d 1, the major allergen of the domestic cat. J Allergy Clin Immunol 1996;98: 884-892.
30. O'Hehir RE, Verhoef A, Panagiotopoulou E, Keswani S, Hayball JD, Thomas WR, Lamb JR: Analysis of human T cell responses to the group II allergen of Dermatophagoides species: Localization of major antigenic sites. J Allergic Clin Immunol 1993;92:105-110.
31. Mark PG, Segal DB, Dallaire ML, Garman RD: Human T and B cell immune responses to Fel d 1 in cat-allergic and non-cat-allergic subjects. Clin Exp Allergy 1996;26:1316-1328.
32. Bungy GA, Rodda S, Roitt I, Brostoff J: Mapping of T cell epitopes of the major fraction of rye grass using peripheral blood mononuclear cells from atopics and non-atopics. II. Isoallergen clone 5A of Lolium perenne group I (Lol p I). Eur J Immunol 1994;24:2098-2103.
33. Schenk S, Breiteneder H, Susani M, Najafian N, Laffer S, Duchene M, Valenta R, Fischer G, Scheiner O, Kraft D, Ebner C: T cell epitopes of Phl p 1, major pollen allergen of timothy grass (Phleum pratense). Crossreactivity with group I allergens of different grasses. Adv Exp Med Biol 1996;409:141-146.
34. Ebner C, Szepfalusi Z, Ferreira F, Jilek A, Valenta R, Parronchi P, Maggi E, Romagnani S, Scheiner O, Kraft D: Identification of multiple T cell epitopes on Bet v I, the major birch pollen allergen, using specific T cell clones and overlapping peptides. J Immunol 1993;150: 1047-1054.
35. Carballido JM, Carballido-Perrig N, Kagi MK, Meloen MH, Wuthrich B, Heusser CH, Blaser K: T cell epitope specificity in human allergic and nonallergic subjects to bee venom phospholipase A2. J Immunol 1993;150:3582-3591.
36. van Neerven FJ, van de Pol MM, van Milligen FJ, Jansen H, Aalberse R, Kapsenberg ML: Characterization of cat dander-specific T lymphocytes from atopic patients. J Immunol 1994;152:4203-4210.
37. Katsuki T, Shimojo N, Honma K, Tsunoo H, Kohno Y, Niimi H: Establishment and characterization of ovalbumin-specific T cell lines from patients with egg allergy. Int Arch Allergy Immunol 1996;109:344-351.
38. Parronchi P, Sampognaro S, Annunziato F, Brugnolo F, Radbruch A, Di Modugno F, Ruffilli A, Romagnani S, Maggi E: Influence of both TCR repertoire and severity of the atopic status on the cytokine secretion profile of Parietaria officinalis-specific T cells. Eur J Immunol 1998;28:37-46.
39. Norman PS, Ohman JL Jr, Long AA, Creticos PS, Gefter MA, Shaked Z, Wood RA, Eggleston PA, Hafner KB, Rao P, Lichtenstein LM, Jones NH, Nicodemus CF: Treatment of cat allergy with T-cell reactive peptides. Am J Respir Crit Care Med 1996;154:1623-1628.
40. Maguire P, Nicodemus N, Robinson D, Aaronson D, Umetsu DT: The safety and efficacy of ALLERVAX CAT in cat allergic patients. Clin Immunol 1999;33:222-231.
41. Charron D, Fauchet R, Albert E, Cambon Thomsen A, Degos L, Hors J, Piazza A, Schreuder I: Genetic diversity of HLA, functional and medical implication: in Charron D (ed): XIIth International Histocompatibility Workshop and Conference. Paris, EDK, 1996, pp 669-671.
42. Texier C, Pouvelle S, Busson M, Hervé M, Charron D, Ménez A, Maillère B:HLA-DR restricted peptide candidates for bee venom immunotherapy. J Immunol 2000;164:3177-3184.
43. Ohman JL, Kendall S, Lowell FC: IgE antibody to cat allergens in an allergic population. J Allergy Clin Immunol 1977;60:317-319.
44. Marcotte GV, Braun CM, Norman PS, Nicodemus CF, Kagey-Sobotka A, Lichtenstein LM, Essayan DM: Effects of peptide therapy on ex vivo T-cell responses. J Allergy Clin Immunol 1998;101:506-513.
45. Simons FE, Imada M, Li Y, Watson WT, Hay-Glass KT: Fel d 1 peptides: Effect on skin tests and cytokine synthesis in cat-allergic human subjects. Int Immunol 1996;8:1937-1945.
46. Pene J, Desroches A, Paradis L, Lebel B, Farce M, Nicodemus CF, Yssel H, Bousquet J: Immunotherapy with Fel d 1 peptides decreases IL-4 release by peripheral blood T cells of patients allergic to cats. J Allergy Clin Immunol 1998;102:571-578.
47. Muller U, Akdis CA, Fricker M, Akdis M, Blesken T, Bettens F, Blaser K: Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom. J Allergy Clin Immunol 1998;101:747-754.
48. Oldfield WLG, Shirley KE, Haselden BM, Larché M, Kay AB: Attenuation of late cutaneous reactions and asthmatic reactions following administration of short allergen-derived T cell peptide epitopes. J Allergy Clin Immunol 2000;104:A1111.
49. Lamb JR, Skidmore BJ, Green N, Chiller JM, Feldmann M: Induction of tolerance in influenza virus-immune T lymphocyte clones with synthetic peptides of influenza hemagglutinin. J Exp Med 1983;157:1434-1447.
50. O'Hehir RE, Yssel H, Verma S, de Vries JE, Spits H, Lamb JR: Clonal analysis of differential lymphokine production in peptide and superantigen induced T cell anergy. Int Immunol 1991;3:819-826.
51. Akdis CA, Akdis M, Blesken T, Wymann D, Alkan SS, Muller U, Blaser K: Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro. J Clin Invest 1996;98:1676-1683.
52. Akdis CA, Blesken T, Akdis M, Wuthrich B, Blaser K: Role of interleukin 10 in specific immunotherapy. J Clin Invest 1998;102:98-106.
53. O'Hehir RE, Lamb JR: Induction of specific clonal anergy in human T lymphocytes by Staphylococcus aureus enterotoxins. Proc Natl Acad Sci USA 1990;87:8884-8888.
54. O'Hehir RE, Aguilar BA, Schmidt TJ, Gollnick SO, Lamb JR: Functional inactivation of Dermatophagoides spp. (house dust mite) reactive human T cell clones. Clin Exp Allergy 1991;21: 209-215.
55. Yssel H, Fasler S, Lamb J, de Vries JE: Induction of non-responsiveness in human allergen-specific type 2 helper cells. Curr Opin Immunol 1994;6:847-852.
56. LaSalle JM, Tolentino PJ, Freeman GJ, Nadler LM, Hafler DA: Early signaling defects in human T cells anergized by T cell presentation of autoantigen. J Exp Med 1992;176:177-186.
57. ck and ZAP-70 tyrosine kinase activities. J Immunol 1997;159:53-60.
58. Lake RA, O'Hehir RE, Verhoef A, Lamb JR: CD28 mRNA rapidly decays when activated T cells are functionally anergized with specific peptide. Int Immunol 1993;5:461-466.
59. Hoyne GF, Askonas BA, Hetzel C, Thomas WR: Regulation of house dust mite responses by intranasally administered peptide: Transient activation of CD4+ T cells precedes the development of tolerance in vivo. Int Immunol 1996;8:335-342.
60. Lowrey JL, Savage ND, Palliser D, Corsin-Jimenez M, Forsyth LM, Hall G, Lindey S, Stewart GA, Tan KA, Hoyne GF, Lamb JR: Induction of tolerance via the respiratory mucosa. Int Arch Allergy Immunol 1998;116:93-102.
61. Suhr C, Sprent J: T-cell apoptosis detected in situ during positive and negative selection in the thymus. Nature 1994;372:100-103.
62. Chen Y, Inobe JL, Marks R, Gonnella P, Kuchroo VK, Weiner HL: Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature 1995;376:177-180.
63. Hoyne GF, Jarnicki AG, Thomas WR, Lamb JR: Characterization of the specificity and duration of T cell tolerance to intranasally administered peptides in mice: A role for intramolecular epitope suppression. Int Immunol 1997; 9:1165-1173.
64. Hoyne GF, Callow MG, Kuo MC, Thomas WR: Inhibition of T-cell responses by feeding peptides containing major and cryptic epitopes: Studies with the Der p I allergen. Immunology 1994;83:190-195.
65. Hoyne GF, Dallman MJ, Lamb JR: Linked suppression in peripheral T cell tolerance to the house dust mite derived allergen Der p 1. Int Arch Allergy Immunol 1999;118:122-124.
66. Secrist H, Chelen CJ, Wen Y, Marshall JD, Umetsu DT: Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals. J Exp Med 1993; 178:2123-2130.
67. Jutel M, Pichler WJ, Skrbic D, Urwyler A, Dahinden C, Muller UR: Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-gamma secretion in specific allergen-stimulated T cell cultures. J Immunol 1995;154:4187-4194.
68. McHugh SM, Deighton J, Stewart AG, Lachmann PJ, Ewan PW: Bee venom immunotherapy induces a shift in cytokine responses from a TH-2 to a TH-1 dominant pattern: Comparison of rush and conventional immunotherapy. Clin Exp Allergy 1995;25:828-838.
69. Hamid QA, Schotman E, Jacobson MR, Walker SM, Durham SR: Increases in IL-12 messenger RNA+ cells accompany inhibition of allergen-induced late skin responses after successful grass pollen immunotherapy. J Allergy Clin Immunol 1997;99:254-260.